MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-UK-06-0003288
Pharma Synth Formulations Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹53.06 Cr
▲ 1% YoY
Net profit · FY 2024
₹12.49 Cr
Net margin 23.5%
EBITDA · FY 2024
₹15.41 Cr
EBITDA margin 29%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Open charges
₹18 Cr
Satisfied ₹24.03 Cr
Company age
33 yrs
Est. 1993
Employees · EPFO
223
Provident fund records
About Pharma Synth Formulations Limited
Data last updated:
Pharma Synth Formulations Limited is a public limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 November 1993 and has been in existence for over 33 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1993PLC056231. Its GSTIN is 07AAACP1657K1ZB (Delhi). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Phoolwati Jain and Ramesh Chand Jain.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at A – 10/15 Jhilmil Industrial Area, Delhi, India – 110095.
As per the financials filed for FY 2024, the company reported a revenue of ₹53.06 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹12.49 Cr (net margin 23.5%) and EBITDA of ₹15.41 Cr (EBITDA margin 29%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 7% over five years.
The company has about 223 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Pharmasynth. As per MCA filings, the company has open charges of ₹18 Cr and satisfied charges of ₹24.03 Cr on record. Court records list 26 cases involving the company, including 18 filed by the company and 8 filed against it; 1 case is pending.
Pharma Synth Formulations Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-06-0003288). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pharmasynth.in.
Company details
CIN U74899DL1993PLC056231
Registration Number 056231
Incorporation Date 26 November 1993
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UK-06-0003288
Recognitions & Rankings of Pharma Synth Formulations
Contact details
Pharma Synth Formulations Limited's registered office is in Delhi, Delhi. Its website is pharmasynth.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressA – 10/15 Jhilmil Industrial Area, Delhi, India – 110095
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Pharma Synth Formulations Limited, buy the company report.
Comprehensive company report
Pharma Synth Formulations Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Pharma Synth Formulations operates one associated brand: Pharmasynth. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, distribution, and social initiatives in India. | pharmasynth.in |
Business activity
The main business activity of Pharma Synth Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Pharma Synth Formulations Limited, buy the company report.
Financials of Pharma Synth Formulations Limited
FY 2024 filings availablePharma Synth Formulations Limited reported revenue of ₹53.06 Cr (up 1% YoY) for FY 2024.
Revenue · FY 2024
₹53.06 Cr ▲ 1%
Net profit · FY 2024
₹12.49 Cr margin 23.5%
EBITDA · FY 2024
₹15.41 Cr margin 29%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 10%
5 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▲ 18%
3 years · compounded
▲ 33%
5 years · compounded
▲ 24%
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 1% growth in the latest year. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹53.06 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15.41 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.49 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 29% | ||||
| Net Profit Margin | 23.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pharma Synth Formulations Limited, buy the company report.
Board of directors of Pharma Synth Formulations Limited
Pharma Synth Formulations has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Phoolwati Jain Also directs: B L D Exports Private Limited | Director | 08 Mar 1994 | 32 Years 7 Months | Current |
| Ramesh Chand Jain | Director | 26 Nov 1993 | 32 Years 10 Months | Current |
| Arvind Kumar Gupta | Director | 26 Nov 1993 | 32 Years 10 Months | Current |
Peer comparison
Pharma Synth Formulations Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Akriti Pharmaceuticals Private Limited | ₹53.84 Cr (FY 2025) | 12.0% | Thane, Maharashtra, India | |||
| Rasino Herbs Private Limited | ₹53.81 Cr (FY 2025) | 4.0% | Mumbai, Maharashtra, India | |||
| Vardhaman Remedies Private Limited | ₹53.36 Cr (FY 2025) | 14.0% | Mumbai, Maharashtra, India | |||
| Pharma Synth Formulations Limitedthis company | ₹53.06 Cr (FY 2024) | ₹12.49 Cr | 23.5% | 1.0% | 223 | Delhi, India |
| Prerana Agrochem Private Limited | ₹52.43 Cr (FY 2025) | 253.0% | Bharuch, Gujarat, India | |||
| Unilink Pharma Private Limited | ₹52.34 Cr (FY 2024) | -18.0% | Chennai, Tamil Nadu, India | |||
| Therallen Pharma Private Limited | ₹52.29 Cr (FY 2025) | 34.0% | Hyderabad, Telangana, India | |||
| Intracin Pharmaceuticals Private Limited | ₹52.07 Cr (FY 2024) | 39.0% | Nadiad, Gujarat, India | |||
| Srivathsa Lifesciences Private Limited | ₹51.99 Cr (FY 2024) | 25.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Pharma Synth Formulations Limited, buy the company report.
Auditor
Pharma Synth Formulations Limited is audited by SAMPRK & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SAMPRK & ASSOCIATES | FY 2024 | 013022N |
Shareholding
The shareholding of Pharma Synth Formulations Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Pharma Synth Formulations Limited, buy the company report.
Charges & borrowings
Open charges
₹18 Cr
Satisfied charges
₹24.03 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Sep 2024 | 100979051 | Sidbi | ₹8 Cr | Open | |
| 13 Sep 2024 | 100979003 | Sidbi | ₹8 Cr | Open | |
| 13 Sep 2024 | 100978996 | Sidbi | ₹2 Cr | Open | |
| 20 Jan 2023 | 100674524 | Sidbi | ₹16 Cr | Satisfied | |
| 28 Mar 2022 | 100551116 | Sidbi | ₹2 Cr | Satisfied |
To see the full charge records of Pharma Synth Formulations Limited, buy the company report.
Total charge records: 16 View all charges
Legal cases
Pharma Synth Formulations Limited has 26 court cases on record: 18 filed by Pharma Synth Formulations, 8 filed against it. 1 case is pending and 25 are disposed.
Total cases
26
Filed by the company
18
Filed against the company
8
Pending
1
Disposed
25
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 17 | 5 | 1 |
| High courts | 8 | 2 | 0 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 26)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Shahdara, Delhi | Interim or miscellaneous application | Filed by the company against M/S Notus Pharmaceuticals P. Ltd. | Disposed |
| District court, Central, Delhi | Civil suit | Filed by the company against Ms. Max Medicare Pvt.Ltd. | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons cases SS) | Filed against the company by State, BKC Bandra (East), Mumbai | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Interim or miscellaneous application | Filed against the company by State of Maharashtra at the Instance of S K Deshmukh, Drugs Inspector, | Disposed |
| High Court of Delhi | Court case (W.C.(C)-IPD) | Filed by the company against Registrar of Trademarks | Disposed |
To see the full case history of Pharma Synth Formulations Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pharma Synth Formulations Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Pharma Synth Formulations Limited has a workforce of 223 employees on its EPFO records as of Mar 11, 2025, across 2 active EPFO establishments.
Employee count
223
Active EPFO establishments
2
Employee growth
3.24%
GST
Pharma Synth Formulations has 4 GST registrations: 2 active and 2 cancelled or inactive.
Total GSTINs
4
Active
2
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACP1657K1ZB | Delhi | Active | 01 Jul 2017 |
| 05AAACP1657K1ZF | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Pharma Synth Formulations Limited, buy the company report.
Recent activity
Pharma Synth Formulations Limited has 3 board changes on record since 1993: 3 appointments. The latest: Phoolwati Jain was appointed as Director on 08 Mar 1994.
AGM
Pharma Synth Formulations Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge registered on 20 Jan 2023 via Charge ID 100674524 with Sidbi was fully satisfied on 24 Sep 2024.
Charges
A charge registered on 28 Mar 2022 via Charge ID 100551116 with Sidbi was fully satisfied on 24 Sep 2024.
Charges
A charge with Sidbi amounted to Rs. 800.00 Lakh with Charge ID 100979051 was registered on 13 Sep 2024.
Charges
A charge with Sidbi amounted to Rs. 800.00 Lakh with Charge ID 100979003 was registered on 13 Sep 2024.
Charges
A charge with Sidbi amounted to Rs. 200.00 Lakh with Charge ID 100978996 was registered on 13 Sep 2024.
Filing
Pharma Synth Formulations Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with Sidbi amounted to Rs. 1,600.00 Lakh with Charge ID 100674524 was registered on 20 Jan 2023.
Charges
A charge with Sidbi amounted to Rs. 200.00 Lakh with Charge ID 100551116 was registered on 28 Mar 2022.
Charges
A charge registered on 29 Jun 2005 via Charge ID 90044801 with Small Industries Development was fully satisfied on 24 Apr 2018.
Charges
A charge registered on 21 Sep 2007 via Charge ID 10069914 with Canara Bank was fully satisfied on 15 Mar 2018.
Charges
A charge registered on 13 Jul 2007 via Charge ID 10061752 with Canara Bank was fully satisfied on 15 Mar 2018.
27 earlier events are in the company report.
Frequently asked questions
Pharma Synth Formulations is an active public limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 November 1993 (33+ years old) and is registered under CIN U74899DL1993PLC056231.
Pharma Synth Formulations has 3 current directors:
- Phoolwati Jain - Director
- Ramesh Chand Jain - Director
- Arvind Kumar Gupta - Director
The latest financial statements of Pharma Synth Formulations on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Pharma Synth Formulations is 07AAACP1657K1ZB, registered in Delhi. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 05AAACP1657K1ZF (Uttarakhand).
The CIN (Corporate Identification Number) of Pharma Synth Formulations is U74899DL1993PLC056231. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pharma Synth Formulations has 26 court cases on record: 18 filed by the company and 8 filed against it. 1 is pending. Most are in the district courts.
Pharma Synth Formulations was incorporated on 26 November 1993, making it 33+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Pharma Synth Formulations by revenue are Akriti Pharmaceuticals Private Limited, Rasino Herbs Private Limited, Vardhaman Remedies Private Limited, Prerana Agrochem Private Limited, Unilink Pharma Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Phoolwati Jain was appointed as Director on 08 Mar 1994. Arvind Kumar Gupta was appointed as Director on 26 Nov 1993. Ramesh Chand Jain was appointed as Director on 26 Nov 1993.
Yes, Pharma Synth Formulations is registered as a small enterprise under Udyam registration (number: UDYAM-UK-06-0003288).
Pharma Synth Formulations can be reached through the website pharmasynth.in. Its registered office is in Delhi, India.